Latest News about FDA
Recent news which mentions FDA
Gene Therapy For Beta-Thalassemia: CRISPR Therapeutics/Vertex's Casgevy Secures FDA Nod Ahead of Schedule
January 17, 2024
From Benzinga
Merck's Crown Jewel Cancer Drug Keytruda Scores FDA Approval For Third Indication In Cervical Cancer
January 16, 2024
From Benzinga
FDA Identifies ResMed's Recall Of Certain Ventilator Device Masks With Magnets As Most Serious
January 12, 2024
From Benzinga
FDA Finds No Evidence Weight-Loss Drugs Cause Suicidal Thoughts
January 11, 2024
From Benzinga
FDA Allows Importing Unapproved But Essential Syphilis Treatment Amid Shortage Of Pfizer's Antibiotic
January 11, 2024
From Benzinga
From Benzinga
From Benzinga
Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD
January 06, 2024
From Benzinga
Hemp Should Be Deemed Compliant Unless It Exceeds 1% Total THC, 1 Of 7 Objectives For New Farm Bill
January 04, 2024
From Benzinga
AMA's Reimbursement Codes For Psychedelic-Assisted Therapies Take Effect: Here's What To Expect
January 03, 2024
From Benzinga
Biden Considers Marijuana Rescheduling: Boon Or Bust For The Industry? Former Top FDA Official Weighs In
January 02, 2024
From Benzinga
Reckitt's Mead Johnson Initiates Massive Recall Of 675K Cans Of Hypoallergenic Baby Formula Over Bacteria Contamination Fears
January 01, 2024
From Benzinga
Kentucky's Promising Opioid Addiction Treatment Initiative Stalls As New AG Ousts Leading Advocate
December 29, 2023
Tickers
NEWS
From Benzinga
2023 Cannabis Year In Review: NORML's Top Ten Events In Marijuana Policy
December 28, 2023
Tickers
NEWS
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.